Evidence map›Paper›PMID 35385164›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2022

Hydrogel cultures reveal Transient Receptor Potential Vanilloid 4 regulation of myofibroblast activation and proliferation in valvular interstitial cells.

Dilara Batan, Douglas K Peters, Megan E Schroeder, Brian A Aguado, Mark W Young, Robert M Weiss, Kristi S Anseth

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. TRPV4-Mediated Mechanosensing Regulates the Endothelial-to-Mesenchymal Transition: Implications for Atherosclerosis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Cell-extracellular matrix mechanotransduction in 3D.Nature reviews. Molecular cell biology · 2023
    Review
  14. Ion Channels in the Development and Remodeling of the Aortic Valve.International journal of molecular sciences · 2023
    Review
  15. Engineered hydrogels for mechanobiology.Nature reviews. Methods primers · 2022
    Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Dilara BatanThe BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.
Douglas K PetersThe BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.
Megan E SchroederThe BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.
Brian A AguadoThe BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.
Mark W YoungThe BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.
Robert M WeissDivision of Cardiovascular Medicine, University of Iowa, Iowa City, Iowa, USA.
Kristi S AnsethThe BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.
University of Colorado Boulder · USUniversity of Iowa · US

Funding

Training In Cardiovascular Physiology & PharmacologyT32HL007444 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Ju Chen, Robert Scott Ross · 1985 to 2026
$11.1M
POSTGRADUATE TRAINING IN CARDIOVASCULAR RESEARCHT32HL007822 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI BUTTRICK, PETER N., LEINWAND, LESLIE ANNE · 1996 to 2023
$6.2M
UCSD PRIDE Faculty Development Program in Cardiovascular SciencesR25HL145817 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Robert Scott Ross, Joann Trejo · 2019 to 2026
$3.3M
Propagation and Resolution of Injury in Calcific Aortic Valve DiseaseR01HL142935 · NHLBI · UNIVERSITY OF IOWA · PI WEISS, ROBERT M · 2018 to 2022
$2.3M
Mechanisms in Polyomavirus AssemblyR01AI151636 · NIAID · UNIVERSITY OF COLORADO · PI GARCEA, ROBERT L · 2020 to 2024
$1.9M
Hydrogels to Study Synergistic Effects of Signaling Factors and Matrix Mechanics on Valve Disease ProgressionR01HL132353 · NHLBI · UNIVERSITY OF COLORADO · PI ANSETH, KRISTI S. · 2017 to 2020
$1.4M
Bioactive Hydrogel Niches for 3D VIC CultureR01HL089260 · NHLBI · UNIVERSITY OF COLORADO · PI ANSETH, KRISTI S. · 2008 to 2011
$1.3M
Investigating sex differences in persistent valvular myofibroblast activation using hydrogel culture substratesK99HL148542 · NHLBI · UNIVERSITY OF COLORADO · PI AGUADO, BRIAN ALBERTO · 2019 to 2020
$256k
Development of a nanotherapy for aortic valve stenosisF32HL137256 · NHLBI · UNIVERSITY OF COLORADO · PI AGUADO, BRIAN ALBERTO · 2017 to 2019
$134k
NHLBI NIH HHS F32 HL137256NHLBI NIH HHS K99 HL148542NHLBI NIH HHS R01 HL089260NHLBI NIH HHS R01 HL132353NHLBI NIH HHS R01 HL142935NHLBI NIH HHS R25 HL145817NHLBI NIH HHS T32 HL007444NHLBI NIH HHS T32 HL007822NIAID NIH HHS R01 AI151636
6 · The paper itself

Abstract

As aortic valve stenosis develops, valve tissue becomes stiffer. In response to this change in environmental mechanical stiffness, valvular interstitial cells (VICs) activate into myofibroblasts. We aimed to investigate the role of mechanosensitive calcium channel Transient Receptor Potential Vanilloid type 4 (TRPV4) in stiffness induced myofibroblast activation. We verified TRPV4 functionality in VICs using live calcium imaging during application of small molecule modulators of TRPV4 activity. We designed hydrogel biomaterials that mimic mechanical features of healthy or diseased valve tissue microenvironments, respectively, to investigate the role of TRPV4 in myofibroblast activation and proliferation. Our results show that TRPV4 regulates VIC proliferation in a microenvironment stiffness-independent manner. While there was a trend toward inhibiting myofibroblast activation on soft microenvironments during TRPV4 inhibition, we observed near complete deactivation of myofibroblasts on stiff microenvironments. We further identified Yes-activated protein (YAP) as a downstream target for TRPV4 activity on stiff microenvironments. Mechanosensitive TRPV4 channels regulate VIC myofibroblast activation, whereas proliferation regulation is independent of the microenvironmental stiffness. Collectively, the data suggests differential regulation of stiffness-induced proliferation and myofibroblast activation. Our data further suggest a regulatory role for TRPV4 regarding YAP nuclear localization. TRPV4 is an important regulator for VIC myofibroblast activation, which is linked to the initiation of valve fibrosis. Although more validation studies are necessary, we suggest TRPV4 as a promising pharmaceutical target to slow aortic valve stenosis progression.

Indexed as

Aortic Valve StenosisCalcinosisMyofibroblastsAnimalsAortic ValveCell ProliferationCells, CulturedHydrogelsSwineTRPV Cation ChannelsHydrogelsTRPV Cation Channelsaortic valve diseasecalcium signalingfibrosishydrogelstransient receptor potential channels

Identifiers

PMID35385164
PMCPMC9009405
OpenAlexW4223471616

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.